Cargando…

Characteristics of pregnant patients with COVID-19 and liver injury

Detalles Bibliográficos
Autores principales:	Deng, Guangtong, Zeng, Furong, Zhang, Lijuan, Chen, Hui, Chen, Xiang, Yin, Mingzhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305728/ https://www.ncbi.nlm.nih.gov/pubmed/32569609 http://dx.doi.org/10.1016/j.jhep.2020.06.022

Ejemplares similares

Clinical determinants for fatality of 44,672 patients with COVID-19
por: Deng, Guangtong, et al.
Publicado: (2020)

Convalescent plasma for patients with COVID-19
por: Zeng, Furong, et al.
Publicado: (2020)

Azvudine versus Paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities
por: Dian, Yating, et al.
Publicado: (2023)

Elevated troponin levels predict the reduced efficacy of Paxlovid in COVID-19 patients
por: Zhao, Deze, et al.
Publicado: (2023)

Association of inflammatory markers with the severity of COVID-19: A meta-analysis
por: Zeng, Furong, et al.
Publicado: (2020)

Clinical Characteristics of COVID-19 in Patients With Liver Injury
por: Chen, Peng, et al.
Publicado: (2020)

Risk and outcomes of breakthrough COVID‐19 infections in vaccinated immunocompromised patients: A meta‐analysis
por: Deng, Guangtong, et al.
Publicado: (2023)

Prognostic value of liver biochemical parameters for COVID-19 mortality
por: Ye, Lin, et al.
Publicado: (2021)

A novel predictive model incorporating immune-related gene signatures for overall survival in melanoma patients
por: Liao, Mengting, et al.
Publicado: (2020)

Liver Injury in COVID-19: Caution and Management
por: Cao, Jiasheng, et al.
Publicado: (2020)

Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes
por: Liu, Furong, et al.
Publicado: (2020)

BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression
por: Zeng, Furong, et al.
Publicado: (2023)

Clinical characteristics of COVID-19 patients with abnormal liver tests
por: Chen, Peng, et al.
Publicado: (2020)

The anti-ferroptotic role of FSP1: current molecular mechanism and therapeutic approach
por: Zeng, Furong, et al.
Publicado: (2022)

Reply to: “Clinical characteristics of COVID-19 patients with abnormal liver tests”
por: Cai, Qingxian, et al.
Publicado: (2020)

Liver injury in COVID-19 – The culprit may not be COVID-19!
por: Singh, Aditya, et al.
Publicado: (2021)

The Topic of COVID-19–Related Liver Injury Needs More Rigorous Research
por: Lv, Xiu-He, et al.
Publicado: (2020)

BET inhibitor suppresses melanoma progression via the noncanonical NF-κB/SPP1 pathway
por: Deng, Guangtong, et al.
Publicado: (2020)

Characteristics and in-hospital outcomes of COVID-19 patients with abnormal liver biochemical tests
por: Wu, Yanyan, et al.
Publicado: (2021)

Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study
por: Sun, Yuming, et al.
Publicado: (2023)

Unfavorable outcomes in pregnant patients with COVID-19
por: Huang, Wenhui, et al.
Publicado: (2020)

Liver injury in remdesivir-treated COVID-19 patients
por: Zampino, Rosa, et al.
Publicado: (2020)

Clinical characteristics of COVID-19 patients with complication of cardiac arrhythmia
por: Liu, Qin, et al.
Publicado: (2020)

Liver Injury in Liver Transplant Patients With COVID-19: A Histopathologic Analysis
por: NG, Alexander
Publicado: (2021)

Clinical Significance of Plasma D-Dimer in COVID-19 Mortality
por: Li, Yayun, et al.
Publicado: (2021)

EEF2K silencing inhibits tumour progression through repressing SPP1 and synergises with BET inhibitors in melanoma
por: Deng, Guangtong, et al.
Publicado: (2022)

Corrigendum to ‘Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study.’ [EClinicalMedicine 59 (2023) 101981]
por: Sun, Yuming, et al.
Publicado: (2023)

COVID-19 Related Liver Injury: Call for International Consensus
por: Ye, Zheng, et al.
Publicado: (2020)

COVID-19-associated liver injury (COVALI): role of hepatologists
por: Sumida, Yoshio, et al.
Publicado: (2021)

Susceptibility to COVID-19 in Pregnant and Breastfeeding Women
por: ALLAH KALTEH, Ehsan, et al.
Publicado: (2020)

Herbal Immune Booster–Induced Liver Injury in the COVID-19 Pandemic
por: Rastogi, Mukul, et al.
Publicado: (2022)

Reply to: “COVID-19-associated liver injury (COVALI): role of hepatologists”
por: Li, Dongxiao, et al.
Publicado: (2021)

Oxygen saturation in pregnant individuals with hemoglobinopathy and COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Should people with chronic liver diseases be vaccinated against COVID-19?
por: Chen, Li-Ping, et al.
Publicado: (2021)

Liver Injury in Severe COVID-19 Disease: Need a Closer Look!
por: Jindal, Ankur
Publicado: (2021)

Prolonged prone position in pregnant woman with COVID-19 pneumonia
por: Linassi, Federico, et al.
Publicado: (2022)

Basic tips for pregnant women during the COVID-19 pandemic
por: Papari, Ioanna
Publicado: (2020)

Inflammatory markers as outcome predictors of COVID-19 in pregnant women
por: Fiorini, Ana Claudia, et al.
Publicado: (2023)

Liver transplantation for acute liver failure due to hepatitis E in a pregnant patient
por: Babu, Rakesh, et al.
Publicado: (2018)

Liver and Kidney Injuries in COVID-19 and Their Effects on Drug Therapy; a Letter to Editor
por: Rismanbaf, Ali, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nf69nsg8nndc4d85q4se327300